WAYNE GOODMAN to Pyrimidines
This is a "connection" page, showing publications WAYNE GOODMAN has written about Pyrimidines.
Connection Strength
0.089
-
Double-blind, placebo-controlled, pilot trial of paliperidone augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder. J Clin Psychiatry. 2013 Jun; 74(6):e527-32.
Score: 0.085
-
The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies. J Clin Psychiatry. 1992 Apr; 53 Suppl:17-28.
Score: 0.005